tDCS and Musical Performance in Young Orchestra Musicians
Launched by CENTRO UNIVERSITÁRIO AUGUSTO MOTTA · Apr 27, 2025
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether a technique called transcranial direct current stimulation (tDCS) can help young musicians perform better and feel less anxious while playing music. Specifically, the study will look at musicians aged 18 to 30 who have at least three years of experience playing in an orchestra. Participants will be divided into two groups: one will receive active tDCS, while the other will get a placebo treatment (sham stimulation) that doesn’t have any real effect. Researchers want to see if those who receive the active treatment perform better musically and feel more confident and less anxious about their performances.
Eligible participants should be healthy young musicians who are currently involved in an orchestra and do not have any history of neurological or psychiatric issues. During the trial, each musician will perform a piece of music before and after receiving stimulation and complete questionnaires about their anxiety and confidence in their musical abilities. It's important to note that the study is not yet recruiting participants, so there’s still time to consider if you or someone you know might be interested in joining.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Musicians aged 18 to 30 years.
- • Minimum of 3 years of orchestral performance experience.
- • Active participation in a stable orchestra or ensemble.
- • No history of neurological or psychiatric disorders.
- • Not currently using psychotropic medications or recreational drugs.
- • Willingness to participate in all study sessions.
- • Signed informed consent form.
- Exclusion Criteria:
- • Presence of metallic implants in the head (e.g., cranial pins, aneurysm clips).
- • Presence of implanted electronic devices (e.g., pacemaker).
- • History of epilepsy or seizures.
- • Prior experience with transcranial direct current stimulation (tDCS).
- • Scalp dermatitis or lesions at the electrode placement sites.
- • Pregnancy.
About Centro Universitário Augusto Motta
Centro Universitário Augusto Motta (CEHAM) is a distinguished higher education institution in Brazil, dedicated to advancing medical research and clinical trials. With a strong emphasis on innovation and scientific excellence, CEHAM fosters an environment that encourages collaboration among health professionals, researchers, and students. The institution is committed to conducting rigorous clinical studies that contribute to the enhancement of healthcare practices and the development of new therapies. CEHAM’s multidisciplinary approach and adherence to ethical standards ensure that its clinical trials are conducted with the utmost integrity, aiming to improve patient outcomes and drive forward the frontiers of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rio De Janeiro, Rj, Brazil
Patients applied
Trial Officials
Ricardo Galhardoni, Ph.D
Principal Investigator
Neuromodulação em Foco
Renato Santos de Almeida, Ph.D
Study Chair
Centro Universitário Augusto Motta
Débora Cristina Lima da Silva, Ph.D
Principal Investigator
Centro Universitário Augusto Motta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported